These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9436178)

  • 1. Inhibitory effects of oxyradicals on surfactant function: utilizing in vitro Fenton reaction.
    Amirkhanian JD; Merritt TA
    Lung; 1998; 176(1):63-72. PubMed ID: 9436178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of pH on surface properties of lung surfactants.
    Amirkhanian JD; Merritt TA
    Lung; 1995; 173(4):243-54. PubMed ID: 7564483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effects of some serum components and proteolytic products of fibrinogen on surface tension-lowering abilities of beractant and a synthetic peptide containing surfactant KL4.
    Manalo E; Merritt TA; Kheiter A; Amirkhanian J; Cochrane C
    Pediatr Res; 1996 Jun; 39(6):947-52. PubMed ID: 8725253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative inactivation of surfactants.
    Andersson S; Kheiter A; Merritt TA
    Lung; 1999; 177(3):179-89. PubMed ID: 10192765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of surfactant mixtures with reactive oxygen and nitrogen species.
    Cifuentes J; Ruiz-Oronoz J; Myles C; Nieves B; Carlo WA; Matalon S
    J Appl Physiol (1985); 1995 May; 78(5):1800-5. PubMed ID: 7649915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium-dependent degradation of surfactant protein A by activated neutrophils due to serine proteases.
    Schochett P; Mora R; Mark L; Butler M; Ingenito EP
    Exp Lung Res; 1999; 25(7):595-616. PubMed ID: 10598320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of budesonide and salbutamol on surfactant properties.
    Palmer D; Schürch S; Belik J
    J Appl Physiol (1985); 2000 Sep; 89(3):884-90. PubMed ID: 10956330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity of synthetic surfactants to albumin inhibition in preterm rabbits.
    Mbagwu N; Bruni R; Hernández-Juviel JM; Waring AJ; Walther FJ
    Mol Genet Metab; 1999 Jan; 66(1):40-8. PubMed ID: 9973546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of peroxynitrite-induced injury to pulmonary surfactants.
    Haddad IY; Ischiropoulos H; Holm BA; Beckman JS; Baker JR; Matalon S
    Am J Physiol; 1993 Dec; 265(6 Pt 1):L555-64. PubMed ID: 8279572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of hydrophobic apoproteins as constituents of clinical exogenous surfactants.
    Hall SB; Venkitaraman AR; Whitsett JA; Holm BA; Notter RH
    Am Rev Respir Dis; 1992 Jan; 145(1):24-30. PubMed ID: 1731593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on biophysical and biochemical surfactant properties.
    Günther A; Schmidt R; Harodt J; Schmehl T; Walmrath D; Ruppert C; Grimminger F; Seeger W
    Eur Respir J; 2002 May; 19(5):797-804. PubMed ID: 12030716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration of alveolar surfactant function after exposure to oxidative stress and to oxygenated and native arachidonic acid in vitro.
    Seeger W; Lepper H; Wolf HR; Neuhof H
    Biochim Biophys Acta; 1985 Jun; 835(1):58-67. PubMed ID: 3924109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Component-specific surface and physiological activity in bovine-derived lung surfactants.
    Notter RH; Wang Z; Egan EA; Holm BA
    Chem Phys Lipids; 2002 Jan; 114(1):21-34. PubMed ID: 11841823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biophysical inhibition of synthetic vs. naturally-derived pulmonary surfactant preparations by polymeric nanoparticles.
    Beck-Broichsitter M; Ruppert C; Schmehl T; Günther A; Seeger W
    Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):474-81. PubMed ID: 24184425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of the surface-tension-lowering ability of surfactant after exposure to hypochlorous acid.
    Merritt TA; Amirkhanian JD; Helbock H; Halliwell B; Cross CE
    Biochem J; 1993 Oct; 295 ( Pt 1)(Pt 1):19-22. PubMed ID: 8216215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of meconium inhibition of pulmonary surfactant by ferric chloride, copper chloride, and acetic acid.
    Almaas R; Robertson B; Linderholm B; Lundberg E; Saugstad OD; Moen A
    Am J Respir Crit Care Med; 2000 Nov; 162(5):1789-94. PubMed ID: 11069814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance of different surfactant preparations to inactivation by meconium.
    Herting E; Rauprich P; Stichtenoth G; Walter G; Johansson J; Robertson B
    Pediatr Res; 2001 Jul; 50(1):44-9. PubMed ID: 11420417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biophysical and physiological properties of a modified porcine surfactant enriched with surfactant protein A.
    Sun B; Curstedt T; Lindgren G; Franzén B; Alaiya AA; Calkovská A; Robertson B
    Eur Respir J; 1997 Sep; 10(9):1967-74. PubMed ID: 9311487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Full length synthetic surfactant proteins, SP-B and SP-C, reduce surfactant inactivation by serum.
    Amirkhanian JD; Bruni R; Waring AJ; Navar C; Taeusch HW
    Biochim Biophys Acta; 1993 Jul; 1168(3):315-20. PubMed ID: 8323972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary importance of zwitterionic over anionic phospholipids in the surface-active function of calf lung surfactant extract.
    Wang Z; Gurel O; Weinbach S; Notter RH
    Am J Respir Crit Care Med; 1997 Oct; 156(4 Pt 1):1049-57. PubMed ID: 9351602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.